Findings of Research Misconduct, 5254-5255 [2012-2276]

Download as PDF 5254 Federal Register / Vol. 77, No. 22 / Thursday, February 2, 2012 / Notices parents of children whose eligibility was established or renewed through ELE methods and parents of children enrolled or renewed through non-ELE routes. The survey component will be conducted using a Dataweb program as well as a paper and pencil option and will involve Medicaid and CHIP program directors from the 50 states and the District of Columbia. Finally, the quarterly monitoring calls will be conducted with a sample of 30 states drawn from both ELE and non-ELE states. ESTIMATED ANNUALIZED BURDEN TABLE Number of responses per respondent Average burden (in hours) per response 18 1 1.5 27 State-level computer programmers .. 6 1 40 240 120 1 1 120 90 1 1 90 240 1 1.5 360 51-State Survey (Attachment F) ....... Quarterly Interview Protocol (Attachment G). Key informants (ELE states— state—and local—levels). Key informants (non-ELE states— state—and local—levels). Focus group participants (2 focus groups in 8 ELE states and 2 focus groups in 4 non-ELE states = 24 focus groups). Medicaid and CHIP officials ............. Key informants (quarterly monitoring calls). 51 30 1 5 45/60 30/60 38 75 Total ........................................... ........................................................... ........................ ........................ ........................ 950 Number of respondents Forms Type of respondent Administrative Cost Discussion Guide (Attachment B). Enrollment Extraction Form (Attachment C). ELE Case Study Protocol (Attachment D1). Non-ELE Case Study Protocol (Attachment D2). Moderator’s Guide (Attachments E1 and E2). Key informants ................................. Keith A.Tucker, Office of the Secretary, Paperwork Reduction Act Reports Clearance Officer. [FR Doc. 2012–2275 Filed 2–1–12; 8:45 am] BILLING CODE 4150–05–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institute for Occupational Safety and Health Final Effect of Designation of a Class of Employees for Addition to the Special Exposure Cohort National Institute for Occupational Safety and Health (NIOSH), Department of Health and Human Services (HHS). ACTION: Notice. AGENCY: HHS gives notice concerning the final effect of the HHS decision to designate a class of employees from the Pantex Plant in Amarillo, Texas, as an addition to the Special Exposure Cohort (SEC) under the Energy Employees Occupational Illness Compensation Program Act of 2000. On December 21, 2011, as provided for under 42 U.S.C. 7384q(b), the Secretary of HHS designated the following class of employees as an addition to the SEC: srobinson on DSK4SPTVN1PROD with NOTICES SUMMARY: All employees of the Department of Energy, its predecessor agencies, and their contractors and subcontractors who worked at the Pantex Plant in Amarillo, Texas, during the period from January 1, 1958 through December 31, 1983, for a number of VerDate Mar<15>2010 17:04 Feb 01, 2012 Jkt 226001 work days aggregating at least 250 work days, occurring either solely under this employment or in combination with work days within the parameters established for one or more other classes of employees included in the SEC. This designation became effective on January 20, 2012, as provided for under 42 U.S.C. 7384l(14)(C). Hence, beginning on January 20, 2012, members of this class of employees, defined as reported in this notice, became members of the SEC. FOR FURTHER INFORMATION CONTACT: Stuart L. Hinnefeld, Director, Division of Compensation Analysis and Support, National Institute for Occupational Safety and Health (NIOSH), 4676 Columbia Parkway, MS C–46, Cincinnati, OH 45226, Telephone (877) 222–7570. Information requests can also be submitted by email to DCAS@CDC.GOV. John Howard, Director, National Institute for Occupational Safety and Health. [FR Doc. 2012–2249 Filed 2–1–12; 8:45 am] BILLING CODE 4163–19–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Office of the Secretary Findings of Research Misconduct Office of the Secretary, HHS. Notice. AGENCY: ACTION: PO 00000 Frm 00028 Fmt 4703 Sfmt 4703 Total burden hours Notice is hereby given that the Office of Research Integrity (ORI) has taken final action in the following case: Calleen S. Zach, Creighton University: Based on evidence obtained from Creighton University (CU) and additional evidence gathered by the Office of Research Integrity (ORI) during its oversight review, ORI found that Ms. Calleen S. Zach, former Research Assistant and Data Base Manager, CU, engaged in research misconduct in research funded by National Institute of Child Health and Human Development (NICHD), National Institutes of Health (NIH), grant R01 HD046991. Specifically, ORI found that the Respondent provided falsified subject enrollment numbers in an application to NIH for continued funding of R01 HD046991 in 2008, a no-cost, one-year extension request for R01 HD046991 (April 8, 2009, letter to NICHD, NIH), and an application for additional funding of R01 HD046991 (June 30, 2009, to NICHD, NIH). In addition, she knowingly and intentionally provided falsified subject enrollment numbers in reports to the CU Institutional Review Board (IRB) in 2008 and 2009. ORI concluded that Respondent’s knowing and intentional falsification of data constitutes research misconduct as defined by 42 CFR 93.103. In addition, ORI found that Respondent’s intentionally deceptive behavior, including false statements made to the CU institutional officials, forgery of petty cash receipts, and theft of NIH SUMMARY: E:\FR\FM\02FEN1.SGM 02FEN1 Federal Register / Vol. 77, No. 22 / Thursday, February 2, 2012 / Notices research grant funds establish a lack of trustworthiness and present responsibility to be a steward of Federal funds. 2 CFR 180.125, 180.800(d), 376.10. The following administrative actions have been implemented for a period of five (5) years, beginning on January 23, 2012: (1) Ms. Zach is debarred from eligibility for any contracting or subcontracting with any agency of the United States Government and from eligibility for, or involvement in, nonprocurement programs of the United States Government, referred to as ‘‘covered transactions’’ as defined in 2 CFR 180.200, 376.10; and (2) Ms. Zach is prohibited from serving in any advisory capacity to the U.S. Public Health Service (PHS), including but not limited to service on any PHS advisory committee, board, and/or peer review committee, or as a consultant. FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 750, Rockville, MD 20852, (240) 453–8800. John Dahlberg, Director, Division of Investigative Oversight, Office of Research Integrity. [FR Doc. 2012–2276 Filed 2–1–12; 8:45 am] BILLING CODE 4150–31–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request Agency for Healthcare Research and Quality, HHS. ACTION: Notice. AGENCY: This notice announces the intention of the Agency for Healthcare Research and Quality (AHRQ) to request that the Office of Management and Budget (OMB) approve the proposed information collection project: ‘‘Assessing the Feasibility of Disseminating EHC Products through Educational Activities.’’ In accordance with the Paperwork Reduction Act, 44 U.S.C. 3501–3521, AHRQ invites the public to comment on this proposed information collection. This proposed information collection was previously published in the Federal Register on November 23rd, 2011 and allowed 60 days for public comment. No substantive comments were received. srobinson on DSK4SPTVN1PROD with NOTICES SUMMARY: VerDate Mar<15>2010 17:04 Feb 01, 2012 Jkt 226001 The purpose of this notice is to allow an additional 30 days for public comment. DATES: Comments on this notice must be received by March 5, 2012. ADDRESSES: Written comments should be submitted to: AHRQ’s OMB Desk Officer by fax at (202) 395–6974 (attention: AHRQ’s desk officer) or by email at OIRA_submission@omb.eop.gov (attention: AHRQ’s desk officer). Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer, (301) 427–1477, or by email at doris.lefkowitz@AHRQ.hhs.gov. SUPPLEMENTARY INFORMATION: Proposed Project Assessing the Feasibility of Disseminating EHC Products through Educational Activities The Agency for Healthcare Research and Quality (AHRQ) requests that the Office of Management and Budget (OMB) approve under the Paperwork Reduction Act of 1995 this collection of information from users of products provided by the John M. Eisenberg Clinical Decisions and Communications Science Center (Eisenberg Center). Information collected consists of feedback from managers, instructors, and learners about these health care guides and other products presented as part of Continuing Medical Education activities. AHRQ is the lead agency charged with supporting research designed to improve the quality of healthcare, reduce its cost, improve patient safety, decrease medical errors, and broaden access to essential services. AHRQ’s Eisenberg Center’s mission is improving communication of research findings to a variety of audiences (‘‘customers’’), including consumers, clinicians, and health care policy makers. The Eisenberg Center compiles research results into useful formats for customer stakeholders. The Eisenberg Center also conducts investigations into effective communication of research findings in order to improve the usability and rapid incorporation of findings into medical practice. The Eisenberg Center is one of three components of AHRQ’s Effective Health Care (EHC) Program. A primary goal of the Eisenberg Center is to translate results from systematic reviews of evidence comparing the effectiveness of two or more clinical care processes into PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 5255 information that can be used to support clinical decision-making. The major products of such efforts are brief guides designed for clinicians, patients, and policy makers that summarize the evidence concerning the effectiveness of various diagnostic and treatment processes. All of the guides and other products are designed to help decision makers, including clinicians and health care consumers, use research evidence to maximize the benefits of health care, minimize harm, and optimize the use of health care resources. The collections proposed under this project include activities to assess the feasibility of disseminating EHC products through Continuing Medical Education (CME) activities, specifically those planned and implemented by member organizations of the Society of Academic Continuing Medical Education (SACME). SACME is an organization with members in both the U.S. and Canada formed in 1976 to ‘‘promote the research, scholarship, evaluation and development of CME and Continuing Professional Development (CPD) that helps to enhance the performance of physicians and other healthcare professionals practicing in the United States, Canada, and elsewhere for purposes of improving individual and population health.’’ For this project, the Eisenberg Center will work with six organizations selected from applications submitted by SACME members that had been invited to compete for funding. The Eisenberg Center selected sites based on the size of each organization’s CME audience, the project’s ability to inform the CME community, its degree of generalizability and replicability, and overall quality. Organizations selected for participation in the feasibility study have committed to specific activities designed to disseminate EHC Program summary guides to physicians, other clinicians, instructional faculty, and clinical researchers who participate in CME activities. Another partner in these efforts is the Association of American Medical Colleges (AAMC), which is assisting the project through access to MedEdPORTAL and CME4docs, two recently launched initiatives that are designed to encourage use of high quality CME resources by medical school faculty and others involved in development and delivery of CME. This research has the following goals: (1) Identify critical factors that enhance or impede integration of EHC products into CME activities; (2) Assess strategies to remove, overcome, or work around barriers to E:\FR\FM\02FEN1.SGM 02FEN1

Agencies

[Federal Register Volume 77, Number 22 (Thursday, February 2, 2012)]
[Notices]
[Pages 5254-5255]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-2276]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Office of the Secretary


Findings of Research Misconduct

AGENCY: Office of the Secretary, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: Notice is hereby given that the Office of Research Integrity 
(ORI) has taken final action in the following case:
    Calleen S. Zach, Creighton University: Based on evidence obtained 
from Creighton University (CU) and additional evidence gathered by the 
Office of Research Integrity (ORI) during its oversight review, ORI 
found that Ms. Calleen S. Zach, former Research Assistant and Data Base 
Manager, CU, engaged in research misconduct in research funded by 
National Institute of Child Health and Human Development (NICHD), 
National Institutes of Health (NIH), grant R01 HD046991.
    Specifically, ORI found that the Respondent provided falsified 
subject enrollment numbers in an application to NIH for continued 
funding of R01 HD046991 in 2008, a no-cost, one-year extension request 
for R01 HD046991 (April 8, 2009, letter to NICHD, NIH), and an 
application for additional funding of R01 HD046991 (June 30, 2009, to 
NICHD, NIH). In addition, she knowingly and intentionally provided 
falsified subject enrollment numbers in reports to the CU Institutional 
Review Board (IRB) in 2008 and 2009.
    ORI concluded that Respondent's knowing and intentional 
falsification of data constitutes research misconduct as defined by 42 
CFR 93.103. In addition, ORI found that Respondent's intentionally 
deceptive behavior, including false statements made to the CU 
institutional officials, forgery of petty cash receipts, and theft of 
NIH

[[Page 5255]]

research grant funds establish a lack of trustworthiness and present 
responsibility to be a steward of Federal funds. 2 CFR 180.125, 
180.800(d), 376.10.
    The following administrative actions have been implemented for a 
period of five (5) years, beginning on January 23, 2012:
    (1) Ms. Zach is debarred from eligibility for any contracting or 
subcontracting with any agency of the United States Government and from 
eligibility for, or involvement in, nonprocurement programs of the 
United States Government, referred to as ``covered transactions'' as 
defined in 2 CFR 180.200, 376.10; and
    (2) Ms. Zach is prohibited from serving in any advisory capacity to 
the U.S. Public Health Service (PHS), including but not limited to 
service on any PHS advisory committee, board, and/or peer review 
committee, or as a consultant.

FOR FURTHER INFORMATION CONTACT: Director, Division of Investigative 
Oversight, Office of Research Integrity, 1101 Wootton Parkway, Suite 
750, Rockville, MD 20852, (240) 453-8800.

John Dahlberg,
Director, Division of Investigative Oversight, Office of Research 
Integrity.
[FR Doc. 2012-2276 Filed 2-1-12; 8:45 am]
BILLING CODE 4150-31-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.